Difference between revisions of "Sargramostim (Leukine)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 12: Line 12:
  
 
==Also known as==
 
==Also known as==
GMCSF, GM-CSF, or granulocyte macrophage colony stimulating factor.
+
*'''Generic names:''' GMCSF, GM-CSF, granulocyte macrophage colony stimulating factor
 +
*'''Brand name:''' Leukine
  
 
==References==
 
==References==
Line 18: Line 19:
  
 
[[Category:Drug index]]
 
[[Category:Drug index]]
[[Category:Hematopoietic growth factors]]
+
[[Category:Subcutaneous medications]]
[[Category:Granulocyte growth factors]]
+
[[Category:Intravenous medications]]
 +
[[Category:Granulocyte macrophage colony-stimulating factors]]
  
 
[[Category:Drugs FDA approved in 1991]]
 
[[Category:Drugs FDA approved in 1991]]

Revision as of 03:52, 17 November 2017

General information

Class/mechanism: Recombinant human granulocyte macrophage colony stimulating factor (GM-CSF), hematopoietic growth factor. Sargramostim binds to cell surface receptors and stimulates survival, proliferation, and differentiation of hematopoietic progenitor cells. In addition to triggering the proliferation of neutrophils, monocytes/macrophages, and myeloid-derived dendritic cells, GM-CSF has also been observed to activate mature granulocytes and macrophages.[1][2][3]
Route: SC, IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Also known as

  • Generic names: GMCSF, GM-CSF, granulocyte macrophage colony stimulating factor
  • Brand name: Leukine

References